DelveInsight’s “Athlete’s Foot Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Athlete’s Foot market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The Athlete’s Foot market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Athlete’s Foot: An Overview
Athlete’s Foot is usually treated with antifungal creams, powders, or sprays that can be obtained by prescription or purchased over the counter. Treatment is usually continued for up to four weeks, although the infection may seem to have disappeared before this.
Medical therapy is the main treatment for Athlete’s Foot. It is treated with topical antifungal agents; however, depending on the patient’s response to topical agents and the severity of the infection, both topical and oral (i.e. systemic) agents may be used. When uncontrolled or if the infection recurs, physicians and dermatologists may prescribe Itraconazole, Griseofulvin, and terbinafine orally as well.
Athlete’s Foot Market Key Facts
-
In a Spanish study, the occurrence of Athlete’s Foot was reported to be low (2.9%) in the general adult population; however, participation in sports and the use of common showers increased the risk of Athlete’s Foot but not the presence of concomitant diseases (e.g., diabetes mellitus, psoriasis or vascular diseases).
-
According to Courtney M Robbins (2020), Athlete’s foot (Tinea pedis) is thought to be the world’s most common dermatophytosis. Reportedly, 70% of the population will be infected with tinea pedis at some time. He also reported that the disease more commonly affects males compared with females.
-
In a systemic review, Fay Crawford (2009) reported that athlete’s foot is present in about 15% of the general population of the United Kingdom.
-
González et al. (2009) carried out a prospective cross-sectional study on 1,305 subjects during the period of 2003–2004. Of the total, 50.1% were male, and 49.9% were female.
The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Athlete’s Foot market size by analyzing the impact of current and emerging pipeline therapies. It also thoroughly assesses the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Athlete’s Foot market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.
Athlete’s Foot Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and views of key opinion leaders.
The Report Covers the Athlete’s Foot Epidemiology, Segmented as –
-
Incidence of Athlete’s Foot in the 7MM [2019–2032]
-
Gender-Specific Incidence of Athlete’s Foot in the 7MM [2019–2032]
-
Age-Specific Incidence of Athlete’s Foot in the 7MM [2019–2032]
-
Type-Specific cases of Athlete’s Foot in the 7MM [2019–2032]
-
Treatable Cases of Athlete’s Foot in the 7MM [2019–2032]
Athlete’s Foot Drugs Uptake and Pipeline Development Activities
The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Athlete’s Foot market or expected to be launched during the study period. The analysis covers the Athlete’s Foot market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Athlete’s Foot pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How the Athlete’s Foot Market Will Evolve and Grow by 2032 @
https://www.delveinsight.com/sample-request/athletes-foot-market
Athlete’s Foot Therapeutics Analysis
The emerging pipeline for the treatment of Athlete’s foot is not robust. Very few candidates are being investigated by pharmaceutical companies in this disease area.
The Leading Players in the Athlete’s Foot Therapeutics Market Include:
-
Bausch Health
-
Dembiont
-
Blueberry Therapeutics
-
Novan
And Many Others
Athlete’s Foot Therapies Covered in the Report Include:
-
Luzu: Ortho Dermatologics
-
TA103: Taro Pharmaceuticals
And Many More
The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @
https://www.delveinsight.com/sample-request/athletes-foot-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Athlete’s Foot Competitive Intelligence Analysis
4. Athlete’s Foot Market Overview at a Glance
5. Athlete’s Foot Disease Background and Overview
6. Athlete’s Foot Patient Journey
7. Athlete’s Foot Epidemiology and Patient Population (In the US, EU5, and Japan)
8. Athlete’s Foot Treatment Algorithm, Current Treatment, and Medical Practices
9. Athlete’s Foot Unmet Needs
10. Key Endpoints of Athlete’s Foot Treatment
11. Athlete’s Foot Marketed Products
12. Athlete’s Foot Emerging Drugs and Latest Therapeutic Advances
13. Athlete’s Foot Seven Major Market Analysis
14. Attribute Analysis
15. Athlete’s Foot Market Outlook (In US, EU5, and Japan)
16. Athlete’s Foot Access and Reimbursement Overview
17. KOL Views on the Athlete’s Foot Market
18. Athlete’s Foot Market Drivers
19. Athlete’s Foot Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download the Sample PDF to Learn More About the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/athletes-foot-market
Take control of your healthcare portfolio with DelveInsight’s comprehensive consulting services. Get in touch and discover how we can help you manage your pharmaceutical portfolio today @ Pharmaceutical Portfolio Management Solutions
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/